Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Stark

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 31, 2018
Cognitive-behavioural treatment of functional neurological symptoms (conversion disorder) in children and adolescents: A case seriesFiona A McFarlane, Hannah Allcott-Watson, Maria Hadji-Michael, et al.
NIHR Open Research|September 8, 2025
Strategy-based cognitive rehabilitation for childhood brain tumour: Protocol for an acceptability and feasibility trial of the Fatigue, Learning, and Memory Enrichment (FLaME) interventionCharlotte P Malcolm, Gerard Anderson, Victoria King, et al.
BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.
The Lancet. Oncology|December 25, 2025
Development of a core outcome set for adolescents and young adults with cancerAnne-Sophie Darlington, Kirsty Way, Nicole Collaço, et al.
Cancer|October 20, 2020
Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International ConsortiumFurqan Shaikh, Daniel Stark, Adriana Fonseca, et al.
Bone & Joint Open|April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective, Sydney Stern, Robert Ashford, et al.
The Lancet. Oncology|June 15, 2016
Paediatric extracranial germ-cell tumoursFurqan Shaikh, Matthew J Murray, James F Amatruda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 18, 2020
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, et al.
Cancer|October 21, 2015
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International CollaborativeFarzana Pashankar, Juliet P Hale, Ha Dang, et al.
Gynecologic Oncology|June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?Rachana Shah, Caihong Xia, Mark Krailo, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 31, 2018
Cognitive-behavioural treatment of functional neurological symptoms (conversion disorder) in children and adolescents: A case seriesFiona A McFarlane, Hannah Allcott-Watson, Maria Hadji-Michael, et al.
NIHR Open Research|September 8, 2025
Strategy-based cognitive rehabilitation for childhood brain tumour: Protocol for an acceptability and feasibility trial of the Fatigue, Learning, and Memory Enrichment (FLaME) interventionCharlotte P Malcolm, Gerard Anderson, Victoria King, et al.
BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.
The Lancet. Oncology|December 25, 2025
Development of a core outcome set for adolescents and young adults with cancerAnne-Sophie Darlington, Kirsty Way, Nicole Collaço, et al.
Cancer|October 20, 2020
Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International ConsortiumFurqan Shaikh, Daniel Stark, Adriana Fonseca, et al.
Bone & Joint Open|April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective, Sydney Stern, Robert Ashford, et al.
The Lancet. Oncology|June 15, 2016
Paediatric extracranial germ-cell tumoursFurqan Shaikh, Matthew J Murray, James F Amatruda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 18, 2020
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, et al.
Cancer|October 21, 2015
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International CollaborativeFarzana Pashankar, Juliet P Hale, Ha Dang, et al.
Gynecologic Oncology|June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?Rachana Shah, Caihong Xia, Mark Krailo, et al.
Pageof 4